NDC 65847-205

NATRECOR

Nesiritide

NATRECOR is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Scios Llc. The primary component is Nesiritide.

Product ID65847-205_12d931dc-a449-4860-ab9f-20211ff766a0
NDC65847-205
Product TypeHuman Prescription Drug
Proprietary NameNATRECOR
Generic NameNesiritide
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2001-08-01
Marketing CategoryNDA / NDA
Application NumberNDA020920
Labeler NameScios LLC
Substance NameNESIRITIDE
Active Ingredient Strength2 mg/5mL
Pharm ClassesNatriuretic Peptide [EPC],Natriuretic Peptides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 65847-205-25

1 VIAL, SINGLE-USE in 1 CARTON (65847-205-25) > 5 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2001-08-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65847-205-25 [65847020525]

NATRECOR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA020920
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-08-01
Marketing End Date2019-05-30

Drug Details

Active Ingredients

IngredientStrength
NESIRITIDE1.5 mg/5mL

OpenFDA Data

SPL SET ID:44c45bfe-461f-4398-8f20-ea771b2403ee
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 883708
  • 883706
  • Pharmacological Class

    • Natriuretic Peptide [EPC]
    • Natriuretic Peptides [CS]

    Trademark Results [NATRECOR]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    NATRECOR
    NATRECOR
    74340210 1841167 Live/Registered
    SCIOS LLC
    1992-12-15

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.